科学家创建了经设计的T细胞,以控制过活性免疫反应,协助移植和自发免疫疾病。 Scientists create engineered T cells to control overactive immune responses, aiding transplants and autoimmune diseases.

San Francisco CUC的科学家开发了工程改造T细胞,作为“裁判”来控制过活性免疫反应,有可能减少对免疫抑制药物的需求。 Scientists at UC San Francisco have developed engineered T cells that act as "referees" to control overactive immune responses, potentially reducing the need for immunosuppressant drugs. 这种技术可以有针对性地使免疫系统平静下来,从而保护移植器官和治疗像1型糖尿病这样的自发免疫条件。 This technology can protect transplanted organs and treat autoimmune conditions like type 1 diabetes by calming the immune system in a targeted manner. 修改后的细胞还可以加强CAR T细胞疗法,以治疗副作用较少的癌症。 The modified cells could also enhance CAR T cell therapies for cancer with fewer side effects.